Fulminant myelopathy following neurogenic proximal weakness associated with human T-cell lymphotropic virus type I infection

3Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

We report a patient with human T-cell lymphotropic virus type I (HTLV-I) infection, who presented with proximal extremity neurogenic muscular weakness followed by fulminant myelopathy, but with no upper motor symptoms. The symptoms were inconsistent with the World Health Organization or El Escorial criteria for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) or amyotrophic lateral sclerosis (ALS). This case indicates that fulminant myelopathy without upper motor neuronal symptoms may occur long after the onset of HTLV-I-associated neurogenic proximal muscular weakness. Additionally, we report that treatment with high-dose steroid pulse therapy partially improves symptoms of lightning pain and sensory disturbance. © 2011 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Yamashita, S., Ueda, A., Hirahara, T., Kimura, E., Hirano, T., & Uchino, M. (2011). Fulminant myelopathy following neurogenic proximal weakness associated with human T-cell lymphotropic virus type I infection. Internal Medicine, 50(8), 919–924. https://doi.org/10.2169/internalmedicine.50.4647

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free